Genetic Evidence for ATP-dependent Endoplasmic Reticulum-to-Golgi Apparatus Trafficking of Ceramide for Sphingomyelin Synthesis in Chinese Hamster Ovary Cells by Fukasawa, Masayoshi et al.
 
ã
 
 The Rockefeller University Press, 0021-9525/99/02/673/13 $2.00
The Journal of Cell Biology, Volume 144, Number 4, February 22, 1999 673Ð685
http://www.jcb.org 673
 
Genetic Evidence for ATP-dependent Endoplasmic
Reticulum-to-Golgi Apparatus Trafficking of Ceramide for
Sphingomyelin Synthesis in Chinese Hamster Ovary Cells
 
Masayoshi Fukasawa, Masahiro Nishijima, and Kentaro Hanada
 
Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
 
Abstract. 
 
LY-A strain is a Chinese hamster ovary cell 
mutant resistant to sphingomyelin (SM)-directed cyto-
lysin and has a defect in de novo SM synthesis. Meta-
bolic labeling experiments with radioactive serine,
sphingosine, and choline showed that LY-A cells were 
defective in synthesis of SM from these precursors, but 
not syntheses of ceramide (Cer), glycosphingolipids, or 
phosphatidylcholine, indicating a specific defect in the 
conversion of Cer to SM in LY-A cells. In vitro experi-
ments showed that the specific defect of SM formation 
in LY-A cells was not due to alterations in enzymatic 
activities responsible for SM synthesis or degradation. 
When cells were treated with brefeldin A, which causes 
fusion of the Golgi apparatus with the endoplasmic 
reticulum (ER), de novo SM synthesis in LY-A cells 
was restored to the wild-type level. PulseÐchase experi-
 
ments with a fluorescent Cer analogue, 
 
N
 
-(4,4-difluoro-
5,7-dimethyl-4-bora-3a,4a-diaza-
 
s
 
-indacene-3-pen-
 
tanoyl)-
 
D
 
-
 
erythro
 
-sphingosine (C
 
5
 
-DMB-Cer), revealed 
that in wild-type cells C
 
5
 
-DMB-Cer was redistributed 
from intracellular membranes to the Golgi apparatus in 
an intracellular ATP-dependent manner, and that
LY-A cells were defective in the energy-dependent
redistribution of C
 
5
 
-DMB-Cer. Under ATP-depleted 
conditions, conversion of C
 
5
 
-DMB-Cer to C
 
5
 
-DMB-SM 
and of [
 
3
 
H]sphingosine to [
 
3
 
H]SM in wild-type cells de-
creased to the levels in LY-A cells, which were not af-
fected by ATP depletion. ER-to-Golgi apparatus traf-
ficking of glycosylphosphatidylinositol-anchored or 
membrane-spanning proteins in LY-A cells appeared 
to be normal. These results indicate that the predomi-
nant pathway of ER-to-Golgi apparatus trafficking of 
Cer for de novo SM synthesis is ATP dependent and 
that this pathway is almost completely impaired in
LY-A cells. In addition, the specific defect of SM syn-
thesis in LY-A cells suggests different pathways of Cer 
transport for glycosphingolipids versus SM synthesis.
Key words: sphingomyelin ¥ ceramide ¥ trafficking ¥ 
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L
 
IPIDS
 
 serve not only as essential constituents of the
fluid matrix of biological membranes, but also as
modulators regulating various cellular events. Mem-
brane lipids of mammalian cells consist mainly of three
different classes of lipids (glycerolipids, sterols, and sphin-
golipids), which are categorized according to the structure
of their hydrophobic backbones. In living cells, the mem-
branes of different intracellular organelles have different
lipid compositions, and various biomembranes show an
asymmetric distribution of lipid types across the mem-
brane bilayer (Alberts et al., 1994). Furthermore, various
steps in lipid biosynthesis can occur in different intracellu-
lar compartments; for example, ceramide (Cer)
 
1
 
 produced
in the ER is sorted to the Golgi apparatus for conversion
to sphingomyelin (SM) or glucosylceramide (GlcCer) (re-
viewed in Hoekstra and Kok, 1992; Rosenwald and Pa-
gano, 1993; van Meer, 1993). Phosphatidylserine produced
 
in the ER is sorted to the mitochondria where phos-
phatidylserine is converted to phosphatidylethanolamine,
which is translocated to the plasma membrane (reviewed
in Trotter and Voelker, 1994). Thus, the synthesis, translo-
cation, and sorting of lipids represent an important set of
problems relating to membrane biogenesis and homeosta-
sis. However, little is known about the mechanisms under-
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PLAP-HA, a chimera of PLAP with influenza hemagglutinin; SM, sphin-
gomyelin; SM synthase, phosphatidylcholine:ceramide cholinephospho-
transferase. 
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lying lipid transport and sorting, although various path-
ways for intracellular transport of newly synthesized lipids
have been suggested (reviewed in Moreau and Cassagne,
1994; Trotter and Voelker, 1994).
Sphingolipid biosynthesis is initiated by condensation
of 
 
L
 
-serine with palmitoyl CoA, a reaction catalyzed by
serine palmitoyltransferase to generate 3-ketodihydro-
sphingosine, which is then converted to dihydrosphin-
gosine (see Merrill and Jones, 1990 for review of sphin-
golipid biosynthesis). Dihydrosphingosine is 
 
N
 
-acylated to
produce dihydroceramide (DCer), followed by desatura-
tion to form Cer. These early synthetic steps occur at the
cytosolic surface of the ER (Mandon et al., 1992; Hirsch-
berg et al., 1993; Michel and van Echten-Deckert, 1997).
Cer, a common intermediate for both SM and glycosphin-
golipid syntheses, is translocated from the ER to the Golgi
apparatus by yet-undefined mechanisms, and then con-
verted to SM by the enzyme phosphatidylcholine:cer-
amide cholinephosphotransferase (SM synthase) in the lu-
menal side of the Golgi apparatus or to GlcCer on the
cytosolic surface of the Golgi apparatus (Coste et al., 1986;
Futerman et al., 1990; Futerman and Pagano, 1991;
Trinchera et al., 1991; Jeckel et al., 1992). After transloca-
tion into the Golgi lumen, GlcCer is further converted to
lactosylceramide and more complex glycosphingolipids.
SM and glycosphingolipids produced in the Golgi lumen
are predominantly delivered to the plasma membrane,
most likely via the bulk flow of membranes from the Golgi
apparatus to the plasma membrane (reviewed in Hoekstra
and Kok, 1992; Rosenwald and Pagano, 1993; van Meer,
1993), while a portion of newly synthesized GlcCer reaches
the plasma membrane by a non-Golgi pathway (Warnock
et al., 1994).
A powerful approach towards understanding the meta-
bolic mechanisms and biological functions of membrane
phospholipids is the biochemical and cell-biological char-
acterization of cell mutants with specific defects in phos-
pholipid metabolism (Nishijima et al., 1997). Lysenin, de-
rived from the coelomic fluid of the earthworm 
 
Eisenia
foetida
 
, is a cytolysin that binds to SM with a high affinity
(Yamaji et al., 1998). Recently, we isolated several types
of lysenin-resistant CHO cell mutants, two of which (des-
ignated LY-A and LY-B strains) are defective in SM pro-
duction, and the LY-B strain has been found to lack the
LCB1 subunit of serine palmitoyltransferase (Hanada et al.,
1998). In this study, we further characterize the LY-A
strain and find that this mutant is defective in an ATP-
dependent trafficking pathway of Cer from the ER to the
Golgi apparatus for de novo SM synthesis. As far as we
are aware, this study is the first report providing genetic
evidence for the existence of specific machinery for intra-
cellular trafficking of Cer. We also discuss models for ER-
to-Golgi apparatus trafficking of de novo synthesized Cer
toward SM or glycosphingolipids.
 
Materials and Methods
 
Materials
 
N
 
-(4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-
 
s
 
-indacene-3-pentanoyl)-
 
D
 
-
 
erythro
 
-sphingosine (C
 
5
 
-DMB-Cer) and 6-[
 
N
 
-(7-nitrobenzo-2-oxa-1,3-
diazol-4-yl)amino]caproyl-
 
D
 
-
 
erythro-
 
sphingosine (C
 
6
 
-NBD-Cer) were pur-
 
chased from Molecular Probes. Brefeldin A, fatty acidÐfree BSA, and
endoglycosidase H (Endo H) were from Sigma Chemical Co. 
 
L
 
-[U-
 
14
 
C]serine (5.85 GBq/mmol) was from Amersham Pharmacia Biotech.
[
 
Methyl
 
-
 
14
 
C]choline chloride (2.04 GBq/mmol) and [3-
 
3
 
H]
 
D
 
-
 
erythro
 
-sphin-
gosine (0.74 GBq/mmol) were from American Radiolabeled Chemi-
cals Inc.
 
Cells and Cell Cultures
 
The CHO-K1 cell line was obtained from the American Type Culture
Collection (ATCC CCL 61), and LY-A strain, a CHO-K1Ðderived mutant
cell line, has been established previously by us (Hanada et al., 1998). Cells
were routinely maintained in HamÕs F-12 medium supplemented with
10% NBS, penicillin G (100 U/ml), streptomycin sulfate (100 
 
m
 
g/ml), and
sodium hydrogen carbonate (1.18 g/liter) at 33
 
8
 
C (Hanada et al., 1990).
Nutridoma medium (HamÕs F-12 medium containing 1% Nutridoma-SP
[Boehringer Mannheim] and gentamicin [25 
 
m
 
g/ml]) was used as serum-
free medium. Cells constitutively expressing a glycosylphosphatidylino-
sitol (GPI)-anchored human placental alkaline phosphatase (PLAP)
(Berger et al., 1987) or a membrane-spanning PLAP (PLAP-HA), which
is a chimera of PLAP with influenza hemagglutinin (Arreaza and Brown,
1995), were established as described (Hanada et al., 1995).
 
Metabolic Labeling of Lipids with [
 
14
 
C]Serine and 
[
 
14
 
C]Choline in Cells
 
Subconfluent cell monolayers in 6-cm dishes were incubated in 2 ml of
Nutridoma medium containing 37 kBq of [
 
14
 
C]serine or [
 
14
 
C]choline at
33
 
8
 
C for various times. After washing twice with 2 ml of cold PBS, cells
were lysed in 1 ml of 0.1% SDS at 4
 
8
 
C, and 0.1 and 0.8 ml of the cell lysate
were used for protein determination and lipid extraction, respectively.
Lipids extracted from the cells (Bligh and Dyer, 1959) were separated on
TLC plates with solvent of methyl acetate/
 
n
 
-propanol/chloroform/metha-
nol/0.25% potassium chloride (25:25:25:10:9, vol/vol) in the [
 
14
 
C]serine-
labeling experiments, or chloroform/methanol/acetic acid/water (25:15:4:2,
vol/vol) in the [
 
14
 
C]choline-labeling experiments. After collecting gels
from the plates by scraping, radioactivity in each lipid was determined by
liquid scintillation counting. The values were normalized to cell protein.
Since DCer and Cer were not separated by the TLC systems used, com-
position of metabolically labeled ceramides was determined after acid hy-
drolysis of them. Cells were labeled with [
 
14
 
C]serine for 2 h at 33
 
8
 
C and la-
beled lipids were separated by the TLC as described above. Lipids
containing both [
 
14
 
C]DCer and [
 
14
 
C]Cer were reextracted from the TLC
fractions, hydrolyzed in 0.5 ml of 10 N hydrochloric acid/water/methanol
(8.6:9.4:100, vol/vol) for 18 h at 70
 
8
 
C (Gaver and Sweeley, 1965), and then
the liberated sphingoid bases were separated on TLC plates with a solvent
of chloroform/methanol/2
 
N
 
 ammonia solution (80:20:1, vol/vol) (Williams
et al., 1984). Radioactivity in separated dihydrosphingosine or sphingosine
was determined by liquid scintillation counting.
For determination of distribution of SM to the external surface of cells,
cells were labeled with [
 
14
 
C]serine for 48 h at 33
 
8
 
C, fixed with 0.125% glu-
taraldehyde in PBS for 30 min at room temperature, and treated with or
without 250 mU/ml of recombinant 
 
Bacillus cereus
 
 sphingomyelinase
(Higeta Shoyu) for 30 min at 37
 
8
 
C. Radioactive SM extracted from the
cells was analyzed as described above.
 
Metabolic Labeling of Lipids with [
 
3
 
H]Sphingosine
in Cells
 
For preparation of a complex of 100 
 
m
 
M [
 
3
 
H]sphingosine (1.85 MBq/ml)
with 200 
 
m
 
M fatty acidÐfree BSA in PBS, a stock solution of [
 
3
 
H]sphin-
gosine (370 KBq, 20 nmol) in ethanol was dried under a stream of nitro-
gen gas. The dried lipid was dispersed in 200 
 
m
 
l of PBS containing 200 
 
m
 
M
fatty acidÐfree BSA by vortex mixing and sonication. Subconfluent cell
monolayers were incubated in Nutridoma medium containing 1 
 
m
 
M
[
 
3
 
H]sphingosine complexed with BSA for various times. Cellular lipids
were extracted under mild alkaline conditions for efficient recovery of the
sphingoid bases (Williams et al., 1984) or mild acidic conditions for effi-
cient recovery of 
 
N
 
-acetylneuramyl lactosylceramide (G
 
M3
 
), and were sep-
arated on TLC plates with a solvent of chloroform/methanol/water (65:25:4,
vol/vol). Radioactivity in each lipid was determined as described above.
 
In Vitro Enzyme Assays
 
Cell lysates were used as the enzyme source for assays. Subconfluent cells 
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were washed twice with PBS, harvested by scraping, and precipitated by
centrifugation (400 
 
g
 
, 5 min). The cells were washed with buffer A (10 mM
Hepes-Na, pH 7.5, containing 0.25 M sucrose and 5 mM EDTA), sus-
pended in buffer A, and lysed with a probe-type sonicator. After removal
of unbroken cells by centrifugation (1,000 
 
g
 
, 5 min), cell lysates were
stored at 
 
2
 
80
 
8
 
C until use.
An assay for SM synthase activity using C
 
5
 
-DMB-Cer was performed
as described (Hanada et al., 1991), except that C
 
5
 
-DMB-Cer was used in-
stead of C
 
6
 
-NBD-Cer. GlcCer synthase activity was determined as de-
scribed (Hanada et al., 1991), except that 500 
 
m
 
M UDP-glucose was in-
cluded in the assay mixture. Dihydrosphingosine 
 
N
 
-acyltransferase (DCer
synthase) activity was determined as described (Morell and Radin, 1970)
except for using [
 
3
 
H]sphingosine instead of [
 
14
 
C]acyl-CoA. Acid and neu-
tral sphingomyelinase activities were determined as described (Schtze
and Krnke, 1995).
 
Metabolism of Fluorescent Cer Analogues in Cells
 
Metabolism of C
 
5
 
-DMB-Cer and C
 
6
 
-NBD-Cer in cells was examined un-
der the pulseÐchase conditions as described (Pagano and Martin, 1988; Pa-
gano et al., 1991) with some modifications. In brief, subconfluent cell
monolayers were incubated in HamÕs F-12 containing 1.25 
 
m
 
M C
 
5
 
-DMB-
Cer complexed with 1.25 
 
m
 
M BSA, or 5 
 
m
 
M C
 
6
 
-NBD-Cer complexed with
5 
 
m
 
M BSA at 4
 
8
 
C for 30 min. Monolayers were washed three times with
HamÕs F-12 and subsequently chased in Nutridoma medium containing
0.34 mg/ml fatty acidÐfree BSA at 33
 
8
 
C for various times. Lipids extracted
from the cells were separated on TLC plates with a solvent of chloroform/
methanol/15 mM calcium chloride (60:35:8, vol/vol). After collecting the
fluorescent spots by scraping, lipids were extracted with 0.5 ml of chloro-
form/methanol/0.1 M potassium chloride (1:2:0.8, vol/vol). NBD (exci-
tation at 470 nm; emission at 530 nm) or DMB (excitation at 480 nm;
emission at 515 nm) fluorescence of each lipid was measured with a spec-
trofluorometer. Values are presented as percentages of total fluorescence
recovered (the sum of C
 
5
 
-DMB-Cer and C
 
5
 
-DMB-SM, or the sum of C
 
6
 
-
NBD-Cer, C
 
6
 
-NBD-SM, and C
 
6
 
-NBD-GlcCer).
 
Fluorescence Microscopy
 
Cells grown on glass coverslips (22-mm diameter) were prelabeled with flu-
orescent lipids at 4
 
8
 
C and chased at 33
 
8
 
C under essentially the same condi-
tions for the labeling of cells grown on culture dishes. After washing with
PBS, the cells were fixed with 0.125% glutaraldehyde solution in PBS for
5 min at 4
 
8
 
C. The fixed specimens were observed and photographed under
a fluorescence microscope. Note that the specimens were photographed
soon after fixation, because redistribution of fluorescent lipid analogues
might occur even in glutaraldehyde-fixed cells (Pagano et al., 1989).
 
Radiolabeling, Immunoprecipitation, and
Endo H Treatment
 
CHO transfectants expressing PLAP or PLAP-HA were pulsed with 9.25
MBq/ml of EXPRESS 
 
35
 
S-protein labeling mix (DuPont-New England
Nuclear) for 15 min at 33
 
8
 
C and chased for various times in Nutridoma
medium containing 10 mM methionine. Radiolabeled cells were washed
and lysed in 0.9 ml of lysis buffer, 50 mM Tris-HCl (pH 8.0) containing 150
mM NaCl, 0.1% SDS, and 1% Triton X-100. After addition of 100 
 
m
 
l of
10% BSA, the cell lysates were boiled for 5 min and clarified by centrifu-
gation twice at 10,000 
 
g
 
 for 10 min. The clarified extracts were incubated
with 2 
 
m
 
l of rabbit antisera against human PLAP (Biomeda Corp.) at 4
 
8
 
C
for 2 h. Resultant immunocomplexes were incubated with 50 
 
m
 
l of a 50%
slurry of protein AÐSepharose CL-4B (Amersham Pharmacia Biotech) at
4
 
8
 
C for 2 h, pelleted, and washed once with lysis buffer containing 1%
BSA and three times with lysis buffer at room temperature. Immunopre-
cipitates were resuspended in 50 mM sodium citrate (pH 5.5) containing
0.5% SDS, 1% 2-mercaptoethanol, and 1 mM 4-amidinophenylmethane-
sulfonyl fluoride, and boiled for 5 min. Immunoprecipitated proteins re-
leased from resin were incubated in the presence or absence of 6 mU of
Endo H at 37
 
8
 
C for 16 h and separated by SDS-PAGE.
 
Protein Determination
 
Protein was determined according to Lowry et al. (1951) or with a BCA
protein assay reagent kit (Pierce Chemical Co.), using BSA as standard.
 
Results
 
Metabolic Labeling of Lipids with [
 
14
 
C]Serine in
LY-A Cells
 
We examined the effects of cell culture temperature on
the activity of de novo SM synthesis in LY-A and wild-
type cells by metabolic labeling of lipids with [
 
14
 
C]serine
for 2 h, and found that the relative levels of SM synthesis
in LY-A cells to that in wild-type cells at 33, 37, and 40
 
8
 
C
were 9.5, 10, and 16%, respectively. Thus, further charac-
terizations of LY-A cells were performed with cells cul-
tured at 33
 
8
 
C, unless otherwise described.
Time courses of metabolic labeling of lipids with [
 
14
 
C]
serine up to 12 h were compared between LY-A and wild-
type cells. As shown in Fig. 1, the SM labeling in LY-A cells
was 
 
,
 
10% of the wild-type level throughout the incuba-
tion. In contrast, time courses for Cer and GlcCer labeling
in LY-A cells were comparable to those in wild-type cells,
although the early labeling rates of these lipids in LY-A
cells were slower than wild-type cells. LY-A and wild-type
cells were virtually identical in the labeling of phosphati-
dylserine or phosphatidylethanolamine, both of which in-
corporate serine via metabolic pathways distinct from the
pathway for sphingolipids. These results confirmed that
LY-A cells are defective in SM synthesis, but not in gly-
cosphingolipid synthesis.
Although DCer comigrated with Cer in the TLC system
used, analysis of sphingoid base composition of metaboli-
cally labeled lipids in the TLC fraction containing both
DCer and Cer showed that 
 
.
 
80% of sphingoid bases de-
rived from the fraction was sphingosine in both LY-A and
Figure 1. Metabolic labeling of lipids with [14C]serine in wild-
type and LY-A cells. Cells were incubated with [14C]serine for
the indicated times at 338C. Radioactivity of each labeled lipid
was determined as described in Materials and Methods. Open
symbols, wild-type CHO cells; closed symbols, mutant LY-A
cells. Circles, phosphatidylserine; squares, phosphatidylethanol-
amine, in the panel named PS & PE. 
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wild-type cells, indicating that conversion of DCer to Cer
is normal in LY-A cells.
For determination of the distribution of SM at the cell
surface, cells were labeled with [
 
14
 
C]serine for 48 h, fixed
with glutaraldehyde, and treated with or without 
 
B
 
.
 
 cereus
 
sphingomyelinase. Analysis of radioactive lipids extracted
from the cells showed that the pool size of sphingomye-
linase-sensitive SM among the total pool of cellular SM
was 56% in wild-type cells and 50% in LY-A cells. Thus,
SM appeared to be preferentially distributed in the outer
leaflet of the plasma membrane bilayer in LY-A cells, as in
wild-type cells.
 
Metabolic Labeling of Lipids with [
 
14
 
C]Sphingosine and 
[
 
14
 
C]Choline in LY-A Cells
 
A defect in SM formation might result in some repression
of de novo sphingoid base formation. Thus, to prevent
such possible feedback repression from affecting Cer-to-
SM conversion by metabolic labeling, we used [
 
3
 
H]sphin-
gosine as an alternative precursor for monitoring SM syn-
thesis, since it has been shown that CHO cells are able to
utilize exogenously supplied sphingosine for synthesis of
Cer and complex sphingolipids (Hanada et al., 1992).
When cells were labeled with 1 
 
m
 
M [
 
3
 
H]sphingosine at
33
 
8
 
C for various times up to 2 h, wild-type and LY-A cells
similarly accumulated free [
 
3
 
H]sphingosine, with a plateau
level at 15Ð30 min after incubation, and showed almost
equal levels of the total radioactivity of cell-associated lip-
ids (Fig. 2), indicating that the two cell types had an equal
efficiency of sphingosine uptake. Under these conditions,
formation of radioactive SM in LY-A cells was 
 
,
 
30% of
the wild-type level throughout the incubation, whereas
formations of Cer, GlcCer, and GM3 were slightly higher in
LY-A cells than in wild-type cells (Fig. 2). When [3H]dihy-
drosphingosine was used as another precursor, we ob-
tained results similar to those obtained with [3H]sphin-
gosine (data not shown).
Synthesis of SM was also examined by metabolic label-
ing with [14C]choline. Incorporation of [14C]choline into
SM in LY-A cells was z20% or less of the wild-type level,
while incorporation of [14C]choline into phosphatidylcho-
line (the phosphorylcholine donor for conversion of Cer to
SM) was slightly higher in LY-A cells than in wild-type
cells (Fig. 3), eliminating the possibility that LY-A cells
had a defect in phosphatidylcholine synthesis.
Cell-free Assays for Activities of Enzymes Involved in 
SM Metabolism
To identify the mechanism underlying the defect in con-
version of Cer to SM in LY-A cells, we examined SM syn-
thase activity in cell lysates by using C5-DMB-Cer, a fluo-
rescent Cer analogue, as the substrate. LY-A cells showed
essentially the same level of SM synthase activity as wild-
type cells, as there was no difference in the dependence of
C5-DMB-SM formation on C5-DMB-Cer concentration or
in the time course of C5-DMB-SM formation between
wild-type and LY-A cells (Fig. 4, A and B). Similarly,
when C6-NBD-Cer or N-[14C]palmitoyl-sphingosine was
used as the substrate, no difference in activity of SM syn-
thase between the two cell types was observed (data not
shown).
We also measured in vitro activities of various other en-
zymes related to SM metabolism including serine palmi-
toyltransferase, dihydroceramide synthase, GlcCer syn-
thase, and acid and neutral sphingomyelinases. However,
significant differences in these activities between wild-type
and LY-A cells were not detected (data not shown; see
Figure 2. Metabolic labeling of sphingolipids with [3H]sphin-
gosine in wild-type and LY-A cells. Cells were incubated with 1 mM
[3H]sphingosine for the indicated times at 338C. Radioactivity of
each labeled lipid was determined as described in Materials and
Methods. Open symbols, wild-type CHO cells; closed symbols,
mutant LY-A cells; So, sphingosine.
Figure 3. Metabolic labeling of lipids with [14C]choline in wild-
type and LY-A cells. Cells were incubated with [14C]choline for
the indicated times at 338C. Radioactivity of each labeled lipid
was determined as described in Materials and Methods. Open
symbols, wild-type CHO cells; closed symbols, mutant LY-A
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also Hanada et al., 1998 for analysis of serine palmitoyl-
transferase activity). Collectively, the results of these in
vivo and in vitro experiments suggested that the specific
defect of SM formation in LY-A cells was not due to alter-
ations in enzymatic activities responsible for SM synthesis
or degradation.
Effect of Brefeldin A on De Novo SM Synthesis in
LY-A Cells
We next explored the possibility that LY-A cells had a de-
fect in translocation of Cer from the ER to the Golgi appa-
ratus where SM synthase exists. Treatment of CHO cells
with brefeldin A, leading to fusion of the Golgi membrane
with the ER (Klausner et al., 1992), enhances the rate of
conversion of Cer to SM, suggesting that in brefeldin
AÐtreated cells Cer is accessible to the normally Golgi ap-
paratusÐlocalized SM synthase without the ER-to-Golgi
apparatus trafficking process (Warnock et al., 1994; van
Helvoort et al., 1997). Thus, if LY-A cells have a defect in
ER-to-Golgi apparatus trafficking of Cer, brefeldin A
treatment should restore SM synthesis in LY-A cells to the
wild-type level.
After pretreatment with 1 mg/ml brefeldin A for 30 min
at 338C, cells were labeled with [14C]serine in the presence
of brefeldin A, and the labeling rates of lipids were com-
pared between wild-type and LY-A cells. Under condi-
tions without brefeldin A, the rate of SM synthesis in LY-A
cells was only 10% of the wild-type level, while the label-
ing rates of other lipids in LY-A cells were comparable to
the wild-type levels (Fig. 1). In contrast, under brefeldin
AÐtreated conditions, the rate of SM synthesis in LY-A
cells was quite similar to the wild-type level, which was about
threefold higher than the rate in brefeldin AÐuntreated
wild-type cells, while labeling rates of Cer, GlcCer, phos-
phatidylserine, and phosphatidylethanolamine were also
similar between wild-type and LY-A cells (Fig. 5). In addi-
tion, we used [3H]sphingosine and [3H]dihydrosphingosine
for monitoring the rate of Cer-to-SM conversion and
observed restoration of SM synthesis in LY-A cells to
the wild-type levels under brefeldin AÐtreated conditions
(data not shown). These results demonstrated that LY-A
cells had the Golgi apparatusÐlocalized SM synthase nor-
mally and suggested that LY-A cells were defective in
translocation of Cer from the ER to the Golgi apparatus.
Figure 4. SM synthase activity in wild-type and LY-A cell ly-
sates. (A) The dependence of C5-DMB-SM formation on a dose
of C5-DMB-Cer. Cell lysate (100 mg protein) was incubated in an
SM synthase assay mixture containing the indicated amounts of
C5-DMB-Cer for 30 min. (B) Time course of C5-DMB-SM for-
mation. Cell lysate (100 mg protein) was incubated in an SM syn-
thase assay mixture containing 10 mM C5-DMB-Cer for the indi-
cated times. C5-DMB-SM produced was determined as described
in Materials and Methods. Open symbols, wild-type CHO lysate;
closed symbols, mutant LY-A lysate. Figure 5. Effect of brefeldin A on metabolic labeling of lipids
with [14C]serine in wild-type and LY-A cells. Cells were preincu-
bated in Nutridoma medium containing 1 mg/ml brefeldin A for
30 min at 338C and then labeled with [14C]serine for the indicated
times at 338C. Radioactivity of each labeled lipid was determined
as described in Materials and Methods. Open symbols, wild-type
CHO cells; closed symbols, mutant LY-A cells. Circles, phos-
phatidylserine; squares, phosphatidylethanolamine, in the panel
named PS & PE.
Figure 6. Metabolism of C5-DMB-Cer in wild-type and LY-A
cells in the presence or absence of brefeldin A. Wild-type CHO
(open circles) and mutant LY-A (closed circles) cells were prein-
cubated in Nutridoma medium without (A) or with (B) 1 mg/ml
brefeldin A for 30 min at 338C, then incubated with 1.25 mM C5-
DMB-Cer for 30 min at 48C. After washing, cell monolayers were
further incubated in Nutridoma medium containing 0.34 mg/ml
BSA without or with 1 mg/ml brefeldin A for the indicated times
at 338C. Cellular lipids were extracted and analyzed by TLC. The
formation of the DMB derivative of GlcCer was too low (,5%
of the level of C5-DMB-SM) to be determined accurately.The Journal of Cell Biology, Volume 144, 1999 678
Metabolism of a Fluorescent Cer Analogue,
C5-DMB-Cer, in LY-A Cells
To examine further whether LY-A cells were defective in
ER-to-Golgi apparatus trafficking of Cer, we used C5-
DMB-Cer, a fluorescent Cer analogue, as a probe. Since
the critical micellar concentration of C5-DMB-Cer is
higher than that of natural Cer (Pagano et al., 1991), exter-
nally supplied C5-DMB-Cer can be readily transferred to
the plasma membrane and, after movement across the
plasma membrane, this probe fluorescently labels various
intracellular membranes including the ER membrane in
living cells at 48C. In addition, when cells prelabeled with
C5-DMB-Cer are warmed up to physiological tempera-
tures, C5-DMB-Cer is efficiently accumulated into the
Golgi region and metabolized to C5-DMB-SM (Pagano
et al., 1991; Ktistakis et al., 1995), indicating the possibility
that the ER-to-Golgi apparatus trafficking behavior of C5-
DMB-Cer mimics that of natural Cer produced at the ER.
For testing whether the behavior of C5-DMB-Cer in
cells reflected the defect of SM synthesis in LY-A cells, the
metabolic rate of C5-DMB-Cer to C5-DMB-SM was com-
pared between wild-type and LY-A cells. Cells were prein-
cubated with C5-DMB-Cer for 30 min at 48C for trans-
ferring the probe to intracellular membranes and, after
washing the extracellular C5-DMB-Cer, cells were incu-
bated at 338C for various times to start conversion of intra-
cellular C5-DMB-Cer to C5-DMB-SM. During the chase,
C5-DMB-Cer was metabolized to C5-DMB-SM in a time-
dependent manner, resulting in conversion of 50% of the
total lipidic fluorescence to C5-DMB-SM in wild-type cells
30 min after the chase, while the metabolic rate of C5-
DMB-Cer to C5-DMB-SM in LY-A cells was about half of
the wild-type level (Fig. 6 A). In addition, the metabolic
rate of C5-DMB-Cer to C5-DMB-SM in LY-A cells was re-
stored to the wild-type level by brefeldin A treatment (Fig.
6 B). Note that the level of total lipidic DMB fluorescence
associated with cells was identical in the two cell types dur-
ing the pulse and chase (data not shown). These results in-
dicated that the behavior of C5-DMB-Cer at least partly
reflects that of natural Cer in cells.
Intracellular Behavior of Pulse-labeled C5-DMB-Cer in 
LY-A Cells
Distribution patterns of intracellular DMB fluorescence
were compared between LY-A and wild-type cells under
the pulseÐchase conditions. After prelabeling of cells with
Figure 7. Intracellular distri-
bution of DMB fluorescence
in wild-type and LY-A cells
over time at 338C after label-
ing with C5-DMB-Cer. Wild-
type CHO (A, C, and E) and
mutant LY-A (B, D, and F)
cells were incubated with
1.25  mM C5-DMB-Cer for 30
min at 48C, washed, further
incubated in Nutridoma me-
dium containing 0.34 mg/ml
BSA for 0 (A and B), 15 (C
and D), or 30 (E and F) min
at 338C, and photographed.
All photomicrographs were
exposed and printed identi-
cally. Bar, 10 mm.Fukasawa et al. ER-to-Golgi Apparatus Trafficking of Ceramide 679
C5-DMB-Cer at 48C, intracellular fluorescence was distrib-
uted throughout intracellular membranes including the
ER in both wild-type and LY-A cells (Fig. 7, A and B).
After the chase at 338C for 15Ð30 min, most of the intracel-
lular fluorescence in wild-type cells accumulated in the
perinuclear region corresponding to the Golgi complex
(Fig. 7, C and E), in agreement with previous studies (Pa-
gano et al., 1991; Ktistakis et al., 1995). Interestingly, accu-
mulation of intracellular fluorescence in the Golgi region
was lower in LY-A cells than wild-type cells (Fig. 7, D and
F vs. C and E). The lower level of the Golgi fluorescence
in LY-A cells was not due to an enhanced secretion of in-
tracellular DMB fluorescence to the medium, because
there was no significant difference in the total amount of
DMB lipids associated with cells between the two cell
types during the pulse and chase periods (data not shown).
These observations also provided evidence that LY-A
cells are defective in ER-to-Golgi apparatus trafficking
of Cer.
Energy Dependence of Redistribution of Intracellular 
C5-DMB-Cer to the Golgi Apparatus
For examination of the energy dependence of intracellular
Figure 8. Effect of ATP de-
pletion on redistribution of
intracellular fluorescence in
wild-type and LY-A cells la-
beled with C5-DMB-Cer or
C6-NBD-Cer. Cells were pre-
incubated in HamÕs F-12 with
or without energy inhibitors
(50 mM 2-deoxy-D-glucose
and 5 mM NaN3) for 15 min
at 338C, then incubated with
1.25 mM C5-DMB-Cer (AÐD)
or 5 mM C6-NBD-Cer (EÐH)
for 30 min at 48C. After wash-
ing, cell monolayers were fur-
ther incubated in Nutridoma
medium containing 0.34 mg/
ml BSA with or without the
inhibitors for 15 min at 338C,
and photographed. (A and E)
Wild-type cells without inhib-
itors; (B and F) mutant LY-A
cells without inhibitors; (C
and G) wild-type cells with
inhibitors; (D and H) mutant
LY-A cells with inhibitors.
For each fluorescent probe,
all photomicrographs were
exposed and printed identi-
cally. Bar, 10 mm.The Journal of Cell Biology, Volume 144, 1999 680
redistribution of C5-DMB-Cer, cells were pretreated with
or without energy inhibitors (50 mM 2-deoxy-D-glucose
and 5 mM NaN3) for 15 min at 338C, incubated with C5-
DMB-Cer for 30 min at 48C, washed, and chased for 15
min at 338C in the presence or absence of the energy inhib-
itors. Measurements of intracellular ATP showed that
wild-type and LY-A cells had the same ATP levels under
the inhibitor-minus control conditions, and ATP levels in
both cell types were reduced by .95% in the presence of
the inhibitors. ATP depletion did not affect the level and
distribution of C5-DMB-Cer during the prelabeling of cells
at 48C; DMB fluorescence was distributed to various intra-
cellular membranes (data not shown), as seen under the
normal conditions (Fig. 7, A and B). However, after the
chase at 338C, the level of DMB fluorescence accumulated
into the Golgi region in wild-type cells was strikingly lower
under the ATP-depleted conditions than under the control
conditions, while in LY-A cells ATP depletion did not ap-
preciably affect the Golgi level of DMB fluorescence (Fig.
8, AÐD). Consequently, ATP depletion reduced the DMB
fluorescence level associated with the Golgi apparatus in
wild-type cells to the level of LY-A cells.
Biochemical analysis showed that the ATP-depleted
conditions caused an z50% reduction of the conversion
rate of C5-DMB-Cer to C5-DMB-SM in wild-type cells
(Fig. 9), indicating that the ATP-dependent redistribution
of C5-DMB-Cer is responsible for synthesis of C5-DMB-
SM in wild-type cells. The reduced rate in wild-type cells
was almost identical to the rate in LY-A cells, which was
not affected by ATP depletion (Fig. 9), being consistent
with the similar level of DMB fluorescence in Golgi appa-
ratus between ATP-depleted wild-type and normally cul-
tured LY-A cells (Fig. 8, B and C). There was no differ-
ence in the total amount of lipidic DMB fluorescence
associated with cells between the normal and ATP-depleted
cells even after the 338C chase (data not shown). Collec-
tively, these results indicated that, in wild-type cells, re-
distribution of intracellular C5-DMB-Cer to the Golgi
apparatus for C5-DMB-SM synthesis consists of an ATP-
dependent pathway(s) and an ATP-independent (or less
ATP-dependent) pathway(s), and that the ATP-depen-
dent trafficking pathway of C5-DMB-Cer is almost com-
pletely impaired in LY-A cells.
Metabolism and Intracellular Behavior of C6-NBD-Cer 
in Cells
While C5-DMB-Cer is a poor substrate for GlcCer syn-
thase (Pagano et al., 1991; Paul et al., 1996), C6-NBD-Cer,
another fluorescent analogue of Cer, serves as an efficient
substrate for both GlcCer and SM syntheses (Futerman
and Pagano, 1991). C6-NBD-Cer has an z10-fold faster
rate at spontaneous transfer between artificial membranes
than C5-DMB-Cer (Rosenwald and Pagano, 1993; Bai and
Pagano, 1997), and C6-NBD-Cer rapidly targets to the
Golgi membrane even in glutaraldehyde-fixed cells, sug-
gesting that no active process is required for ER-to-Golgi
apparatus transfer of C6-NBD-Cer (Pagano et al., 1989).
Under normal culture or ATP-depleted conditions, wild-
type and LY-A cells were preincubated with C6-NBD-Cer
at 48C to label intracellular membranes and, after washing
extracellular C6-NBD-Cer, cells were incubated at 338C
for the chase. During the chase, C6-NBD-Cer was con-
verted to C6-NBD-SM or C6-NBD-GlcCer in a time-depen-
dent manner with redistribution of NBD fluorescence to
the Golgi apparatus, in agreement with a previous study
(Lipsky and Pagano, 1983). In contrast to the cases with
C5-DMB-Cer (Figs. 8, AÐD, and 9 A), redistribution of C6-
NBD-Cer to the Golgi region or conversion of C6-NBD-
Cer to C6-NBD-SM was not affected by ATP depletion
even in wild-type cells, and C6-NBD-Cer behaved almost
identically between LY-A and wild-type cells (Figs. 8,
EÐH, and 9 B). The conversion rate of C6-NBD-Cer to C6-
NBD-GlcCer under the ATP-depletion conditions was
z70Ð75% of the normal level, probably due to a decrease
in the intracellular UDP-glucose level by ATP depletion.
These results indicated that C6-NBD-Cer is efficiently re-
distributed to the Golgi apparatus not via the ATP-depen-
dent pathway, which is involved in the redistribution of C5-
DMB-Cer to the Golgi apparatus. However, this nature of
C6-NBD-Cer allowed us to demonstrate that the ATP-
depleted conditions used did not cause an inhibition of SM
synthase activity itself or extensive destruction of the
Golgi apparatus.
Effects of ATP Depletion on SM and GlcCer Formation 
from [3H]Sphingosine
We next examined the effect of ATP depletion on conver-
sion of natural Cer to SM by metabolic labeling with
[3H]sphingosine. ATP depletion of wild-type cells resulted
in the reduction of the [3H]SM formation to the level of
LY-A cells, which was not affected by ATP depletion (Fig.
10), being consistent with the results of the pulseÐchase
experiments using C5-DMB-Cer (Fig. 9 A). Although the
[3H]SM formation in wild-type cells under the ATP-
depleted conditions was only 30% of the normal level, the
Figure 9. Metabolism of C5-DMB-Cer and C6-NBD-Cer in nor-
mal and ATP-depleted cells over time. Cells were preincubated
in HamÕs F-12 with or without energy inhibitors (50 mM 2-deoxy-
D-glucose and 5 mM NaN3) for 15 min at 338C, then incubated
with 1.25 mM C5-DMB-Cer (A) or 5 mM C6-NBD-Cer (B) for 30
min at 48C. After washing, cell monolayers were further incu-
bated in Nutridoma medium containing 0.34 mg/ml BSA with or
without the inhibitors for the indicated time at 338C. Lipids ex-
tracted from the cells were separated by TLC, and the amounts
of C5-DMB-SM (solid lines in A), C6-NBD-SM (solid lines in B),
and C6-NBD-GlcCer (dotted lines in B) were determined. For-
mation of C5-DMB-GlcCer was too low to be quantified. Closed
circles, wild-type cells without inhibitors; open circles, wild-type
cells with inhibitors; closed squares, mutant LY-A cells without
inhibitors; open squares, mutant LY-A cells with inhibitors.Fukasawa et al. ER-to-Golgi Apparatus Trafficking of Ceramide 681
[3H]GlcCer formation under the ATP-depleted conditions
was z65% of the normal level both in wild-type and LY-A
cells (Fig. 10). Considering that GlcCer formation ap-
peared to be partially inhibited by a reduction of the
UDP-glucose level under the ATP-depletion conditions,
effects of ATP depletion on accessibility of [3H]Cer to SM
and GlcCer synthases could be estimated by the corrected
values of [3H]SM/C6-NBD-SM and [3H]GlcCer/C6-NBD-
GlcCer, respectively, although we did not eliminate the
possibility that access of C6-NBD-Cer to SM and GlcCer
synthases was not completely ATP independent. The cor-
rected values suggested that the influence of ATP deple-
tion on [3H]Cer trafficking caused z70% and z20% inhi-
bition of [3H]SM and [3H]GlcCer formation, respectively
(Fig. 10, bottom). ATP depletion did not reduce the level
of [3H]sphingosine associated with cells and did cause an
increase in the level of [3H]Cer along with the striking de-
crease in [3H]SM, ruling out the possibility that the de-
creased formation of [3H]SM under the ATP-depleted
conditions was due to a decrease in cellular uptake of
[3H]sphingosine or formation of [3H]Cer from [3H]sphin-
gosine. These results demonstrated evidence that traffick-
ing of natural Cer from the ER to the site for SM synthesis
is mainly ATP dependent and that this ATP-dependent
trafficking of Cer is defective in LY-A cells.
ER-to-Golgi Apparatus Trafficking of GPI-anchored 
and Membrane-spanning Glycoproteins in LY-A Cells
To address the question of whether ER-to-Golgi appara-
tus trafficking of proteins was affected in LY-A cells, we
determined the acquisition rate of Endo H resistance, a
well-accepted determinant for arrival in the medial Golgi
apparatus (Kornfeld and Kornfeld, 1985). For this, we
used wild-type and LY-A cells constitutively expressing
GPI-anchored alkaline phosphatase (PLAP) or chimeric
alkaline phosphatase (PLAP-HA) having a membrane-
spanning region in place of the GPI anchor. PLAP and
PLAP-HA in these cells were pulse-labeled with [35S]me-
thionine/cysteine for 15 min and chased for various time at
338C. Then, extracts from the cells were immunopre-
cipitated with anti-PLAP antibody, treated with Endo H,
and separated by SDS-PAGE for detection of the Endo
HÐsensitive and Ðresistant forms. From the data shown in
Fig. 11, the acquisition rates of Endo H resistance of not
only PLAP but also PLAP-HA were quite similar (t1/2 5
z30 min) between wild-type and LY-A cells. Thus, it was
likely that the machinery for ER-to-Golgi apparatus traf-
ficking of glycoproteins operated normally in LY-A cells.
Discussion
LY-A Cells Have a Specific Defect in an
ATP-dependent Trafficking Pathway of Cer from the 
ER to the Golgi Compartment for De Novo
SM Synthesis
Previously, we isolated the LY-A strain, a CHO cell mu-
tant resistant to an SM-directed cytolysin, and showed that
LY-A cells have only a 30% level of SM content, but
nearly a 100% level of glycosphingolipid content com-
pared with wild-type cells (Hanada et al., 1998). In this
study, we attempted to identify a defective step causing
the phenotype of LY-A cells.
Metabolic labeling experiments with [14C]serine, [3H]
sphingosine, and [14C]choline indicated that conversion of
Cer to SM was impaired in LY-A cells, but that the forma-
tions of Cer and phosphatidylcholine, both of which are
immediate precursors for SM formation, are normal (Figs.
1Ð3). However, enzyme assays in cell lysates showed no
difference in the activities of SM synthase, neutral sphin-
gomyelinase, or acid sphingomyelinase between LY-A
and wild-type cells. Although reduced SM synthesis along
with Cer accumulation was observed during the mitotic
phase of the cell cycle (Yokoyama et al., 1997), LY-A and
wild-type cells grown in Nutridoma medium displayed vir-
tually identical patterns of the phase distribution of the
cell cycle; 30Ð32% of the total population of each cell type
was in the G1 phase, 50Ð54% in the S phase, and 15Ð17%
in the G2 plus M phases (data not shown). These in vivo
Figure 10. Effect of ATP depletion on metabolism of sphingolip-
ids labeled by [3H]sphingosine in wild-type and LY-A cells. (Top
and middle) After ATP depletion of cells as described in the leg-
end to Fig. 9, wild-type CHO (WT) and mutant LY-A cells were
incubated with 1 mM [3H]sphingosine for 30 min at 338C. Radio-
activity of each labeled lipid was determined as described in Ma-
terials and Methods. The values of [3H]lactosylceramide and
[3H]GM3 were both ,10% of those of [3H]GlcCer. (Bottom) For
the estimation of specific effects of ATP depletion on accessibil-
ity of [3H]Cer to SM and GlcCer synthases, the corrected values
of [3H]SM/C6-NBD-SM and [3H]GlcCer/C6-NBD-GlcCer are
shown as percentages of the value of normal cultured wild-type
cells. The values of NBD-SM and -GlcCer formation are from
the data shown in Fig. 9 B. N, normal culture conditions; D, ATP-
depleted conditions; So, sphingosine.The Journal of Cell Biology, Volume 144, 1999 682
and in vitro experiments suggested that the defect of SM
formation in LY-A cells was not due to alterations in enzy-
matic activities responsible for SM metabolism nor to a
secondary effect of cell-cycle phase on the lipid metabo-
lism, leading us to the possibility that LY-A cells had a de-
fect in translocation of Cer from the ER to the Golgi com-
partment where SM synthase exists.
Several lines of evidence support this conclusion. First,
when cells were treated with brefeldin A, SM synthesis
in LY-A cells was restored to the wild-type level (Fig.
5), in agreement with the expectation that in brefeldin
AÐtreated cells Cer is accessible to the normally Golgi ap-
paratusÐlocalized SM synthase without the ER-to-Golgi
apparatus trafficking process. Second, pulseÐchase experi-
ments with C5-DMB-Cer in intact cells demonstrated that
redistribution of intracellular DMB fluorescence from in-
tracellular membranes to the Golgi apparatus is strikingly
slower in LY-A cells than in wild-type cells (Fig. 7), along
with the defect of conversion of C5-DMB-Cer to C5-DMB-
SM in intact LY-A cells (Fig. 6 A). Furthermore, ATP
depletion in wild-type cells inhibited the conversion of C5-
DMB-Cer to C5-DMB-SM by 50% and also inhibited
redistribution of C5-DMB-Cer to the Golgi apparatus,
whereas ATP depletion did not affect the behavior of C5-
DMB-Cer in LY-A cells (Figs. 8, AÐD, and 9 A). Although
conversion of C6-NBD-Cer to the SM metabolite may be
necessary for trapping NBD fluorescence in the Golgi ap-
paratus (Ptz and Schwarzmann, 1995), at least a portion
of the Golgi apparatusÐaccumulated DMB fluorescence in
wild-type cells appears to be attributable to unconverted
C5-DMB-Cer, because the amount of C5-DMB-SM formed
in LY-A cells after a 30-min chase was equivalent to that
of C5-DMB-SM formed in wild-type cells after a 15-min
chase (Fig. 6 A), whereas DMB fluorescence in the Golgi
region was much denser in the latter cells than in the
former (Fig. 7, C and F). By contrast, intracellular labeling
with C6-NBD-Cer, which rapidly transfers between mem-
branes, displayed no difference in the Golgi redistribution
between LY-A and wild-type cells, or between normally
cultured and ATP-depleted cells (Fig. 8, EÐH). Thus, the
impairment of the Golgi accumulation of C5-DMB-Cer in
LY-A cells reflects a defect in the energy-dependent trans-
port of this probe from intracellular membranes to the
Golgi apparatus. In addition, the findings that intracellular
DMB fluorescence is initially distributed throughout intra-
cellular membranes after prelabeling with C5-DMB-Cer at
48C (Fig. 7, A and B; see also Pagano et al., 1991) and that
.50% of the surface area of intracellular membranes is at-
tributed to the ER membrane (Griffiths et al., 1989) indi-
cate that the energy-dependent redistribution of DMB
fluorescence most likely represents an ER-to-Golgi appa-
ratus transport of C5-DMB-Cer. Importantly, this energy-
dependent trafficking of C5-DMB-Cer is relevant to
physiological trafficking of natural Cer for SM synthesis,
because ATP depletion in wild-type cells inhibited [3H]SM
formation from metabolically labeled [3H]Cer, whereas
[3H]SM formation in LY-A cells was not affected by ATP
depletion (Fig. 10). Collectively, we conclude that LY-A
cells are defective in ATP-dependent trafficking of Cer
from the ER to the Golgi compartment where SM syn-
thase exists.
The defect in LY-A cells appears to be specific to Cer
transport. When cellular lipids were metabolically labeled
with [14C]serine, the formation rates of [14C]phosphati-
dylserine and [14C]phosphatidylethanolamine were identi-
cal between LY-A and wild-type cells (Fig. 1), indicating
that transport of phosphatidylserine from the ER to the
mitochondria proceeds normally in LY-A cells. Choles-
terol metabolism in LY-A cells is also suggested to be nor-
mal, since the amount of free cholesterol in LY-A cells is
the wild-type level (Hanada et al., 1998). There was no ap-
preciable difference in the acquisition rate of Endo H re-
sistance of a membrane-spanning or a GPI-anchored pro-
tein between LY-A and wild-type cells (Fig. 11), indicating
that ER-to-Golgi apparatus trafficking of proteins is not
defective in LY-A cells. Both wild-type and LY-A cells
display a similar preferential distribution of SM at the
plasma membrane (data not shown), suggesting that, once
SM is produced in the Golgi apparatus, SM is subse-
quently sorted to the plasma membrane in LY-A cells sim-
ilar to wild-type cells.
Our findings that in wild-type CHO cells ATP depletion
inhibits conversion of C5-DMB-Cer to C5-DMB-SM by
50% concomitantly with inhibition of redistribution of intra-
cellular DMB fluorescence to the Golgi apparatus (Figs. 8
and 9 A) suggest that a z50% portion of ER-to-Golgi
apparatus transfer of C5-DMB-Cer is mediated via the
ATP-dependent pathway and that another 50% of the C5-
DMB-Cer transfer is mediated by ATP-independent (or
less ATP-dependent) mechanisms. The ATP-independent
redistribution of C5-DMB-Cer to the Golgi apparatus may
be at least partly attributable to a nonphysiological spon-
taneous transfer of C5-DMB-Cer between membranes due
to less hydrophobicity of C5-DMB-Cer than natural Cer.
For natural Cer, ATP-dependent and -independent (or
less ATP-dependent) trafficking mechanisms were esti-
Figure 11. ER-to-Golgi apparatus trafficking of GPI-anchored
or membrane-spanning glycoprotein in wild-type and LY-A cells.
Cells were pulsed for 15 min with [35S]methionine/cysteine and
chased for the indicated time. Immunoprecipitates were treated
with Endo H for 16 h at 378C and separated by SDS-PAGE as
described in Materials and Methods. (A and C) Wild-type CHO
cell derivatives expressing PLAP and PLAP-HA, respectively;
(B and D) mutant LY-A cell derivatives expressing PLAP and
PLAP-HA, respectively. R, Endo HÐresistant form; S, Endo
HÐsensitive form; C, cleaved form by Endo H.Fukasawa et al. ER-to-Golgi Apparatus Trafficking of Ceramide 683
mated to be responsible for 70Ð80% and 20Ð30%, respec-
tively, of newly synthesized SM, since ATP depletion
caused a 70Ð80% inhibition of formation of [3H]sphin-
gosine-derived SM without reduction of [3H]Cer forma-
tion (Fig. 10). In contrast, redistribution of intracellular
C6-NBD-Cer to the Golgi apparatus or conversion of C6-
NBD-Cer to C6-NBD-SM was not, or only slightly, af-
fected by ATP depletion. The different trafficking behav-
ior between C5-DMB-Cer and C6-NBD-Cer most likely
reflects the fact that C6-NBD-Cer has a much faster rate of
spontaneous transfer between artificial membranes than
C5-DMB-Cer (Rosenwald and Pagano, 1993; Bai and Pa-
gano, 1997), implying that C5-DMB-Cer is embedded in
membranes more firmly and thus mimics natural Cer more
accurately, compared with C6-NBD-Cer.
Different Pathways of Cer Transport for SM versus 
GlcCer Synthesis
It has been postulated that a yet-undefined pathway(s)
mediates Cer trafficking from the ER to the Golgi appara-
tus and that, after arrival at the cytoplasmic surface of the
Golgi apparatus, Cer molecules are used for GlcCer syn-
thesis and the residual Cer molecules are subsequently
used for SM synthesis after translocation to the lumenal
side of the Golgi apparatus (reviewed in Hoekstra and
Kok, 1992; Rosenwald and Pagano, 1993; van Echten and
Sandhoff, 1993; van Meer, 1993). Collins and Warren
(1992) have shown that newly synthesized Cer can be de-
livered to the sites of SM and GlcCer synthases by a differ-
ent pathway from the major vesicular-mediated trafficking
pathway for newly synthesized proteins during the mitotic
phase in HeLa cells. Slomiany et al. (1992) have demon-
strated that Cer-containing vesicles derived from the ER
fuse with the Golgi membrane in an N-ethylmaleimideÐ
sensitive manner under cell-free conditions. On the other
hand, studies with another cell-free system and with a
semi-intact cell system to assay for the transfer of Cer be-
tween the ER and the Golgi membranes have suggested
that Cer could be transferred from the ER to the Golgi ap-
paratus through a nonvesicular pathway in ATP-indepen-
dent and N-ethylmaleimideÐinsensitive manners (Moreau
et al., 1993; Kok et al., 1998).
If ER-to-Golgi apparatus trafficking of Cer is mediated
by only one pathway, it would be a paradox that LY-A
cells synthesize GlcCer to the wild-type level or more, in
spite of the defect of the ATP-dependent ER-to-Golgi ap-
paratus trafficking of Cer. A possible explanation for the
paradoxical phenotype of LY-A cells is that the putative
sole pathway for ER-to-Golgi apparatus Cer trafficking
might be narrowed in LY-A cells, but that the narrowed
pathway might still supply enough Cer to produce a nor-
mal level of GlcCer in the Golgi apparatus, but not of SM.
However, this explanation is not consistent with the obser-
vation that formations of [3H]GlcCer and [3H]GM3 from
[3H]sphingosine were somewhat higher in LY-A cells than
in wild-type cells (Fig. 2). It is unlikely that the reduced
synthesis of SM results from an overconsumption of newly
synthesized Cer at the GlcCer synthesis step, since the
level of [3H]sphingosine-derived Cer was higher in LY-A
cells than in wild-type cells (Fig. 2) and there was no dif-
ference in GlcCer synthase activity between the two cell
types (data not shown). Another possibility is that a trans-
bilayer transport of Cer across the Golgi membranes is im-
paired in LY-A cells. However, the observation that SM
synthesis in LY-A cells was restored to the wild-type level
after brefeldin A treatment (Fig. 5) favors the interpreta-
tion that the phenotype of LY-A cells is primarily due to a
defect in the interorganelle transport of Cer, although we
cannot completely exclude the possibility that brefeldin A
treatment facilitates a transbilayer transport of Cer across
the membrane where SM synthase exists, thereby restor-
ing SM synthesis to LY-A cells. Considering that SM syn-
thase as well as ganglioside synthases are suggested to
exist more distally in the Golgi complex than GlcCer syn-
thase (Futerman and Pagano, 1991; Jeckel et al., 1992; van
Echten and Sandhoff, 1993), an intraÐGolgi apparatus
transport of Cer might be specifically blocked in LY-A
cells. If so, one could expect accumulation of Cer in a pre-
or early Golgi region. However, there was no sign of such
specific redistribution of C5-DMB-Cer in LY-A cells (Fig.
7), although this observation does not conflict with the al-
ternative expectation that a block of the intraÐGolgi appa-
ratus transport of Cer causes recycling of C5-DMB-Cer to
the ER instead of its accumulation in the early Golgi appa-
ratus. Note that LY-A cells normally produce GM3 (Fig.
2), eliminating the possibility that intraÐGolgi apparatus
transport pathways of various sphingolipid types are non-
specifically blocked in LY-A cells.
Therefore, we considered another possible mechanism
that Cer, produced at the ER, is accessible to GlcCer syn-
thase by different pathways from the ATP-dependent traf-
ficking pathway which is impaired in LY-A cells. This
mechanism appears to be consistent with the characteris-
tics of LY-A cells; for example, the overflow of Cer to gly-
cosphingolipids in LY-A cells could be mediated by the
putative pathway responsible for GlcCer synthesis. The
observation that an ATP depletion of wild-type cells
caused  z70% inhibition of [3H]sphingosine-derived [3H]SM
formation, but only z20% inhibition of [3H]GlcCer for-
mation (Fig. 10), may also be accounted for by the notion
that Cer is efficiently accessible to GlcCer synthase by
ATP-independent (or less ATP-dependent) trafficking, al-
though there could be the alternative explanation that a
minor population of GlcCer synthase is distributed to the
ER in CHO cells, so that Cer produced at the ER is acces-
sible to the ER-distributed GlcCer synthase without an in-
terorganelle transport. Collectively, we propose that there
are at least two pathways for Cer trafficking from the ER
to the site of de novo SM synthesis: the ATP-dependent
major pathway, which is impaired in LY-A cells, and the
ATP-independent (or less ATP-dependent) minor path-
way(s). This scenario appears to occur in various types of
mammalian cells since depletion of intracellular ATP in
HeLa cells and human skin fibroblasts affected redistribu-
tion of C5-DMB-Cer to the Golgi apparatus and conver-
sion of C5-DMB-Cer to C5-DMB-SM (data not shown), as
observed in wild-type CHO cells (Figs. 8 and 9 A).
Two hypothetical models may be conceivable to explain
the preferential delivery of Cer to SM synthase by the
ATP-dependent mechanism. In one model (Fig. 12 A), a
portion of newly synthesized Cer molecules is rapidly in-
ternalized to the lumenal side of the ER, and the lumenal
Cer is delivered to the Golgi apparatus via an ATP-depen-The Journal of Cell Biology, Volume 144, 1999 684
dent and vesicle-mediated pathway for SM synthesis, while
Cer remaining at the cytosolic side of the ER is delivered
to the cytosolic side of the Golgi apparatus via an ATP-
independent (or less ATP-dependent) pathway for GlcCer
synthesis. In another model (Fig. 12 B), regardless of the
Cer topology in the ER membrane, a portion of the Cer
molecules enters an ATP-dependent pathway, which is
specifically directed to the Golgi subcompartment where
SM synthase is localized, while Cer molecules associated
with an ATP-independent (or less ATP-dependent) path-
way have a broader specificity for their destination and are
eventually accessible to both GlcCer and SM synthases. If
LY-A cells have a deficiency in an intraÐGolgi apparatus
transport of Cer, it may be conceivable that the ATP-
dependent step for specific delivery to the SM synthaseÐ
localizing compartment is located at the intraÐGolgi appa-
ratus transport of Cer.
Membrane proteins are delivered from the ER to the
Golgi apparatus by vesicular transport mechanisms (Roth-
man and Orci, 1990), and the same mechanisms for pro-
tein trafficking may be involved in the ATP-dependent
trafficking of Cer. However, since LY-A cells exhibit no
appreciable defect in ER-to-Golgi apparatus trafficking
of proteins, we currently speculate that the machine de-
fective in LY-A cells could be a specific device for Cer
transport. There might be multiple, independent vesicular
transport pathways from the ER to the Golgi apparatus,
one of which is exclusive for Cer. For further elucidation
of the molecular mechanism underlying the intracellular
trafficking of Cer, additional studies, including identifica-
tion of the genes related to this function, will be necessary,
and the LY-A strain will be a useful tool for this purpose
as well.
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